|
|
Vol. 22.37 – 25 October, 2021
|
|
|
|
|
|
|
|
Investigators presented the design of light-switchable CAR T cells that allowed real-time phototunable activation of therapeutic T cells to precisely induce tumor cell killing. [Nature Nanotechnology]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Researchers demonstrated that murine and human T helper (Th) 9 cells, but not Th1/Tc1 or Th17 cells, expressing tumor-specific T cell receptors or CARs, eradicated advanced tumors that contained antigen-loss-variants.
[Cancer Cell]
|
|
|
|
|
|
In vitro results showed that mesenchymal stem cell-small extracellular vesicles reduced senescent biomarkers, decreased senescence-associated secretory phenotype, rescued angiogenesis, migration and other dysfunctions in senescent endothelial cell induced by oxidative stress.
[Signal Transduction and Targeted Therapy]
|
|
|
|
|
|
Sequential libraries of ionizable lipid nanoparticle formulations with varied excipient compositions were screened in comparison to a standard formulation for improved mRNA delivery to T cells with low cytotoxicity, revealing B10 as the top formulation with a 3-fold increase in mRNA delivery.
[Nano Letters]
|
|
|
|
|
|
Investigators described a chemotherapy-induced, host-mediated mechanism that promoted remodeling of the extracellular matrix, ultimately facilitating cancer cell seeding and metastasis.
[Cancer Research]
|
|
|
|
|
|
To reprogram the functional capacities specifically of engineered CAR T cells, researchers inserted IL12 into the extracellular moiety of a CD28-ζ CAR.
[Molecular Therapy]
|
|
|
|
|
|
The authors found that donor engraftment in the myeloid compartment was significantly diminished in unconditioned procedures, which typically use a HLA-matched sibling donor or family donor.
[Journal of Clinical Immunology]
|
|
|
|
|
|
Scientists evaluated the ability of mast cells and mesencymal stem cells to induce angiogenesis in a rat model of ischemic hind limb injury on a background of a tissue engineered hydrogel scaffold. [Scientific Reports]
|
|
|
|
|
|
Researchers investigated the efficiency and prognostic role of cytoplasmic CD79a antibody-gated multicolor flow cytometry in minimal residual disease detection in patients with B-cell acute lymphoblastic leukemia who received CD19-targeted CAR T cell therapy bridging to allogeneic hematopoietic stem cell transplantation.
[Leukemia & Lymphoma]
|
|
|
|
|
|
|
|
|
The authors discuss gene editing approaches that have been the best studied in the context of human T cells and adoptive T cell therapies, summarizing their current status and near-term potential for translation. [Molecular Therapy]
|
|
|
|
|
|
Investigators provide a comprehensive review of the challenges associated with autologous CAR, and the benefits and potential challenges associated with allogenic-CAR.
[British Journal of Haematology]
|
|
|
|
|
|
CAR-engineered natural killer (NK)-92 cells have demonstrated robust antitumor activity in in vitro and in vivo preclinical studies, propelling the clinical development of CAR NK-92 cells. [Molecular Therapy-Oncolytics]
|
|
|
|
|
|
|
|
BioCardia®, Inc. announced the treatment of the first patient in its Phase III pivotal CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial for patients with no option chronic myocardial ischemia with refractory angina.
[BioCardia®, Inc.]
|
|
|
|
|
|
Ambulero, Inc. announced that the US FDA’s Office For Orphan Products Development granted the company’s request for orphan drug status for its gene therapy candidate, AMB-301, to treat Buerger’s Disease, also known as Thromboangiitis Obliterans.
[Ambulero, Inc. (GlobeNewswire, Inc.)]
|
|
|
|
|
|
The SynGAP Research Fund announced grants to Drs. April Levin, Mustafa Sahin and Annapurna Poduri of Boston Children’s Hospital to advance SYNGAP1 biomarker characterization and genotype-phenotype analysis. [SynGAP Research Fund]
|
|
|
|
|
|
|
|
November 9 – 10, 2021 Montpellier, France
|
|
|
|
|
|
|
|
|
|
|
Gordian Biotechnology – San Francisco, California, United States
|
|
|
|
|
|
|
Cedars-Sinai Medical Center – Los Angeles, California, United States
|
|
|
|
|
|
|
Hong Kong University – Hong Kong, China
|
|
|
|
|
|
|
Boston Children’s Hospital – Boston, Massachusetts, United States
|
|
|
|
|
|
|
The International Society for Cell & Gene Therapy – Vancouver, British Columbia, Canada
|
|
|
|
|
|